Table 1. Molecules Predicted as SARS-CoV Mpro Inhibitors with Experimental Evidence.
| compound name | source | ref | compound name | source | ref |
|---|---|---|---|---|---|
| (+)-dihydromyricetin | COVID-19 DB | (21,22) | isoginkgetin | article | (25) |
| (−)-epigallocatechin gallate | article, COVID-19 DB | (23) | isorhamnetin (3-methylquercetin) | article | (25) |
| isochlorogenic acid A | article | (24) | isoschaftoside | article | (27) |
| acteoside | article | (24) | liquiritin | article, COVID-19 DB | (24) |
| amentoflavone (didemethyl-ginkgetin) | article | (25) | luteolin | article | (25) |
| andrographoiside | article | (24) | luteoloside | article | (24) |
| andrographolide | article, COVID-19 DB | (24) | myricetin | COVID-19 DB | (21) |
| apigenin | article | (25) | narcissin | article | (27) |
| baicalin | article, COVID-19 DB | (24) | pectolinarin | article, COVID-19 DB | (24) |
| chlorogenic acid | article, COVID-19 DB | (24) | procyanidin | COVID-19 DB | (28) |
| curcumin | article | (23) | quercetin | article | (23) |
| ellagic acid | article | (23) | rutin (quercetin 3-rutinoside) | article, PostEra DB, COVID-19 DB | (29) |
| emodin | article | (26) | silibinin | COVID-19 DB | (30) |
| ginkgetin | article | (25) | tannic acid | COVID-19 DB | (31) |
| glycyrrhizin | article, COVID-19 DB | (24) | theaflavin | COVID-19 DB | (31,32) |
| hyperoside (quercetin 3-galactoside) | article | (27) | wogonoside | article | (24) |
| isochlorogenic acid B | article | (24) |